Ligand Pharmaceuticals Inc
LGND
Revenue
41.53M
▲10.55M▲34.07%
3 Months ChangeAssets
866.41M
▼-47.46M▼-5.19%
3 Months ChangeLiabilities
91.21M
▼-16.14M▼-15.04%
3 Months ChangeFree Cash Flow
18.63M
▼-12.91M▼-40.93%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-07
Form 10-Q
ID: 0000886163-24-000071
2024-08-06
Form 8-K
ID: 0000886163-24-000067
2024-08-02
Form 8-K
ID: 0000886163-24-000064
2024-07-17
Form 8-K
ID: 0000886163-24-000061
2024-07-10
Form 8-K
ID: 0000886163-24-000059
2024-07-08
Form 8-K
ID: 0000886163-24-000053
2024-06-27
Form 8-K
ID: 0000886163-24-000051
2024-06-18
Form 8-K
ID: 0000886163-24-000047
2024-06-17
Form 8-K
ID: 0000886163-24-000045
2024-05-30
Form 8-K
ID: 0000886163-24-000039